DAULAT MEDHORA's most recent trade in Fredun Pharmaceuticals Ltd. was a Acquisition of 18,068 Equity Shares done at an average price of Rs. 996.2 . Disclosure was reported to the exchange on Aug. 25, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for DAULAT MEDHORA in the Trendlyne database.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fredun Pharma | DAULAT MEDHORA | Promoter & Director | Acquisition | 25 Aug 2023 | 18,068 | 1,410,898 (30.38%) | 0.39% | 996.2 | 17,999,342 | 23 Aug 2023 23 Aug 2023 |
Insider Trading | Equity Shares | Allotment |
Fredun Pharma | Daulat Medhora | Promoter & Director | Acquisition | 18 Oct 2022 | 18,068 | 18,068 (0.38%) | 0.41% | 996.2 | 17,999,342 | 15 Oct 2022 15 Oct 2022 |
Insider Trading | Warrants | Allotment |
Fredun Pharma | Daulat Medhora | Promoter & Director | Acquisition | 25 Nov 2021 | 52,120 | 1,392,830 (31.42%) | 1.31% | 422.1 | 21,999,852 | 23 Nov 2021 23 Nov 2021 |
Insider Trading | Equity Shares | Allotment |
Fredun Pharma | Daulat Medhora | Promoter & Director | Acquisition | 22 Nov 2021 | 52,210 | 52,210 (1.17%) | 1.31% | 421.4 | 21,999,852 | 17 Nov 2021 17 Nov 2021 |
Insider Trading | Warrants | Allotment |